Tg Therapeutics (TGTX) EBITDA Margin (2017 - 2026)
Tg Therapeutics (TGTX) recorded EBITDA Margin of 9.04% in Q2 2026, down 15.65 percentage points from 24.69% a year earlier and down 7.96 percentage points from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) EBITDA Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Tg Therapeutics' EBITDA Margin came in at 17.07% as of Jun 30, 2026, down 1.85 percentage points year-over-year; for FY2025, it came in at 20.02%, up 7.26 percentage points from FY2024.
- Annual EBITDA Margin has increased for three straight years, with a five-year change of +179627.92 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 12.76% in FY2024 (+3.84 pp), 8.92% in FY2023 (+7829.42 pp), -7820.50% in FY2022 (-2673.60 pp) and -5146.90% in FY2021 (+174461.00 pp).
- The Q2 2026 figure is the lowest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of +4.00 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 223956.38 percentage points in Q4 2021, against a drop of 92767.37 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 17.00% (Q1 2026), 26.23% (Q4 2025) and 18.17% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Tg Therapeutics | 8.60 Bn | 7.99 Bn | 199.14 Mn | 9.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.04% |
| Mar 31, 2026 | 17.00% |
| Dec 31, 2025 | 26.23% |
| Sep 30, 2025 | 18.17% |
| Jun 30, 2025 | 24.69% |
| Mar 31, 2025 | 7.14% |
| Dec 31, 2024 | 27.69% |
| Sep 30, 2024 | 14.84% |
| Jun 30, 2024 | 12.03% |
| Mar 31, 2024 | -14.56% |
| Dec 31, 2023 | -28.31% |
| Sep 30, 2023 | 69.30% |
| Jun 30, 2023 | -277.40% |
| Mar 31, 2023 | -472.52% |
| Dec 31, 2022 | -96,766.25% |
| Sep 30, 2022 | -37,057.45% |
| Jun 30, 2022 | -6,533.67% |
| Mar 31, 2022 | -3,310.66% |
| Dec 31, 2021 | -3,998.88% |
| Sep 30, 2021 | -4,187.14% |
API Access
Tg Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();